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Whole-genome expression profiling revealed Escherichia coli
MG1655 genes induced by growth on mucus, conditions designed
to mimic nutrient availability in the mammalian intestine. Most
were nutritional genes corresponding to catabolic pathways for
nutrients found in mucus. We knocked out several pathways and
tested the relative fitness of the mutants for colonization of the
mouse intestine in competition with their wild-type parent. We
found that only mutations in sugar pathways affected coloniza-
tion, not phospholipid and amino acid catabolism, not gluconeo-
genesis, not the tricarboxylic acid cycle, and not the pentose
phosphate pathway. Gluconate appeared to be a major carbon
source used by E. coli MG1655 to colonize, having an impact on
both the initiation and maintenance stages. N-acetylglucosamine
and N-acetylneuraminic acid appeared to be involved in initiation,
but not maintenance. Glucuronate, mannose, fucose, and ribose
appeared to be involved in maintenance, but not initiation. The in
vitro order of preference for these seven sugars paralleled the
relative impact of the corresponding metabolic lesions on coloni-
zation: gluconate > N-acetylglucosamine > N-acetylneuraminic
acid  glucuronate > mannose > fucose > ribose. The results of
this systematic analysis of nutrients used by E. coli MG1655 to
colonize the mouse intestine are intriguing in light of the nutrient-
niche hypothesis, which states that the ecological niches within the
intestine are defined by nutrient availability. Because humans are
presumably colonized with different commensal strains, differ-
ences in nutrient availability may provide an open niche for
infecting E. coli pathogens in some individuals and a barrier to
infection in others.
E scherichia coli is the predominant facultative anaerobe in thegastrointestinal tracts of mammals (1). It is arguably the best
understood of all model organisms, yet the essence of how E. coli
colonizes its mammalian hosts is not understood (2). In fact, very
little is known about the acquisition and metabolism of nutrients
that underpin the growth and persistence of colonized micro-
organisms.
The intestinal biota is remarkably diverse, containing an
estimated 500 different bacterial species (1, 3–5). Freter’s nu-
trient-niche theory postulates that numerous ecological niches
within the intestine are defined by nutrient availability (6, 7).
According to this hypothesis, individual species have a prefer-
ence for one, or very few, of the nutrients that come from
ingested food, epithelial and bacterial cell debris, and the mucus
layer lining the epithelium. The diversity of available nutrients
is thought to result in a balanced ecosystem in which each
nutrient-defined niche is occupied by an individual bacterium,
with individual population sizes determined by the available
concentration of the preferred nutrient.
The majority of intestinal bacteria require a fermentable
carbohydrate for growth, and fermentation is assumed to be the
mode of metabolism used by most species (8). Most carbohy-
drate in the colon is in the form of mucosal polysaccharides,
which are degraded by a few anaerobes that dominate the
intestinal biota (9–11). The monosaccharides released from
mucin and other mucosal glycoproteins support the growth of
many intestinal bacteria such as E. coli, which does not make
polysaccharide-degrading enzymes (10). Because the population
of individual species is proportional to the concentration of its
preferred nutrient(s), the relatively low population of E. coli in
the intestine indicates that the concentration of its preferred
nutrient(s) is low.
A large and growing body of evidence indicates that com-
mensal E. coli grows in the intestine on nutrients acquired from
mucus. Fluorescence in situ hybridization of intestinal thin slices
showed that E. coli BJ4 (12) and MG1655 (13) are dispersed in
the mucus layer. E. coli BJ4 grows rapidly in the mouse intestine,
with a generation time of 40–80 min (14). In vitro, rapid growth
(30-min generation time) occurs in intestinal mucus, but not in
luminal contents (15, 16). Among mutants unable to colonize the
mouse intestine are those that fail to penetrate mucus (13, 17),
have difficulty surviving in mucus (18), or have difficulty growing
on mucus (16, 18, 19). Thus, the ability of E. coli to grow and
survive in mucus appears critical for intestinal colonization.
It is important to understand how gastrointestinal pathogens
acquire the nutrients necessary to infect their hosts and initiate
the disease process. This understanding of host–pathogen inter-
actions should build on knowledge of model systems. Thus, we
conducted a genome-wide search for metabolic pathways used by
E. coli K-12 to colonize the mouse intestine. Here we present the
gene expression profile of E. coli MG1655 grown in vitro on
mucus as the sole source of carbon and energy, conditions that
mimic nutrient availability in the mouse intestine. The induced
pathways were systematically eliminated by gene knockouts and
the mutants were tested for their relative colonization fitness.
The results are discussed in terms of the nutrient-niche hypoth-
esis and the prediction that the commensal E. coli f lora serves
as a first line of defense against E. coli intestinal pathogens.
Methods
Bacterial Strains and Growth Conditions. Strains derived from E.
coli MG1655 StrR (streptomycin-resistant) and E. coli MG1655
StrR NalR (nalidixic acid-resistant) were used throughout this
work (13). For DNA array experiments, cells were grown in
triplicate at 37°C without shaking in 18-mm test tubes containing
5 ml of the Mops-based culture medium designed by Neidhardt
et al. (20). Mouse cecal mucus was prepared from streptomycin-
treated CD-1 mice (not colonized with E. coli), as described
previously (13). Cultures were grown in triplicate to early (OD600
 0.1) or late (OD600  0.3) logarithmic phase in 5 or 10 mgml
lyophilized mucus. For in vitro nutrient preference experiments,
cultures were grown in 96-well microtiter plates containing 100
l of Mops minimal medium supplemented with the indicated
carbon sources, incubated in a plate reader (FLUOstar Optima,
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BMG Labtechnologies, Offenburg, Germany) at 37°C, and the
OD600 was measured every 10 min. Enzymatic BioAnalysis sugar
test kits were obtained from Boehringer Mannheim.
Mutant Constructions. Knockout mutants were constructed by
allelic replacement with kanamycin- or chloramphenicol-
resistance cassettes, as described by Datsenko and Wanner (21).
Primers used to construct deletion mutants were designed
according to the E. coli MG1655 genome sequence (22). Mutants
were confirmed for their growth phenotype and sequenced for
genotype confirmation.
DNA Array Analysis of E. coli MG1655 in Mouse Cecal Mucus. Isolation
of total RNA, labeling of samples, and duplicate hybridization to
matched Panorama E. coli membrane arrays (Sigma-GenoSys,
Woodlands, TX) were described previously (23–25). Raw data
were imported into an Oracle database, normalized by express-
ing individual spot intensities as a fraction of the sum of all
gene-specific spot intensities in each image, and analyzed as
described previously (24). Clustering algorithms were executed
in Spotfire DECISIONSITE FOR FUNCTIONAL GENOMICS software
(Spotfire, Somerville, MA). The data and protocols are available
on our web site (www.ou.edumicroarray).
Mouse Colonization Experiments. The relative fitness of E. coli
strains for colonization of the mouse intestine was assayed as
described (13, 16, 19). Briefly, three male CD-1 mice (5–8 weeks
old) were given drinking water containing streptomycin sulfate
(5 gliter) for 24 h to eliminate resident facultative bacteria (26).
After 18 h of starvation for food and water, the mice were fed
1 ml of 20% sucrose containing 105 to 106 colony-forming units
(cfu) of both the wild-type and mutant strains. After ingestion of
the bacterial suspension, food and streptomycinwater were
returned to the mice. Fecal plate counts were obtained after 5 h,
24 h, and on odd-numbered days thereafter. The NalR and
antibiotic resistance markers introduced by allelic replacement
had no effect on colonization in control experiments (19). The
colonization experiments are available on the Internet (www.
ou.edumicroarray).
Results
Gene Expression Profiles of Mucus-Grown E. coli MG1655. We deter-
mined the gene expression profile of E. coli MG1655 under
conditions designed to mimic nutrient availability in the intes-
tine. In the first ‘‘low-mucus’’ experiment, E. coli MG1655 was
cultured on 5 mgml mouse cecal mucus and compared with cells
grown on glucose (Fig. 1). Significantly induced genes directed
our attention to pathways for catabolism of amino sugars:
N-acetylglucosamine (NAG), N-acetylneuraminic (sialic) acid,
and glucosamine; pentoses: fucose and ribose; amino acids:
tryptophan, threonine, serine, and aspartate; and phosphati-
dylethanolamine. The low-mucus data set also indicated elevated
expression of the tricarboxylic acid (TCA) cycle, gluconeogen-
esis, and anaerobic respiration (data not shown).
Surprisingly, there was no evidence in the low-mucus exper-
iment for induction of genes involved in catabolism of preferred
nutrients such as gluconate and mannose, which are known
components of mucus (15). Therefore, the experiment was
repeated with a higher concentration (10 mgml) of mucus (Fig.
1 and Table 1). Induction of genes for catabolism of sugar acids
such as gluconate occurred in early logarithmic phase (phase 1)
Fig. 1. Expression profiles of E. coli MG1655 genes involved in catabolism of
carbohydrates found in mucus (15). Genes are represented in rows, as indi-
cated to the right, and are grouped by the corresponding sugar degradation
pathway. PH1, ratio of early logarithmic phase (OD600 0.1) cells grown on 10
mgml mucus vs. minimal glucose (0.2%); PH2, from the same culture grown
to late logarithmic phase (OD600  0.3); Low, ratio of cells grown to late
logarithmic phase (OD600 0.3) on 5 mgml mucus vs. minimal glucose; Cont,
ratio of cells grown to late logarithmic phase on chemically defined rich
medium (20) vs. minimal glucose. Ratios are displayed colorimetrically: bright
red indicates genes with2.5-fold higher expression (2 standard deviations)
and bright green indicates 2.5-fold lower expression in the experimental
condition compared with minimal glucose; the colors darken to black to
indicate no change in expression. GlcNAc, N-acetylglucosamine; GalNAc, N-
acetylgalactosamine; NANA, sialic acid (N-acetylneuraminic acid); GlcNH4,
glucosamine. See text for further details.
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(Fig. 1). The relative induction ratios for the sugar acid genes
declined at the later time point (phase 2), explaining why
induction of these genes was not detected in the first experiment.
Comparison of phases 1 and 2 revealed other subtleties of growth
on mucus: genes involved in catabolism of gluconate, glucur-
onate, sialic acid, NAG, mannose, maltose, and ribose were
induced at the early time point, whereas genes involved in
degradation of ethanolamine and fucose, anaerobic respiration,
and the TCA cycle were induced at the later time point (Fig. 1).
Significantly induced genes other than those involved in metab-
olism are shown in Table 1, but they were not considered further.
To determine whether E. coli can consume building blocks
directly from mucus, we examined the expression profile of
biosynthesis genes, assuming that exogenous amino acids and
nucleosides would cause repression. Thirty of 97 amino acid and
6 of 66 nucleotide biosynthetic genes were significantly repressed
in cells grown on mucus compared with glucose (data not
shown). Supplementation of mucus medium with amino acids
and nucleosides had no effect (i.e., additional biosynthetic genes
were not repressed). These results suggest that E. coli can acquire
purines, pyrimidines, and amino acids from mucus, thus increas-
ing the partitioning of sugars into energy-yielding pathways as
opposed to biosynthesis.
In summary, the gene expression profiles of mucus-grown E.
coli MG1655 identified genes involved in catabolism of NAG,
sialic acid, glucosamine, fucose, ribose, glucuronate, galactur-
onate, gluconate, and maltose. There was also evidence for
catabolism of phospholipids and amino acids, which require the
TCA cycle and gluconeogenesis. These data were the starting
point for testing the roles of individual nutrients in supporting E.
coli colonization of the mouse.
Genes, Pathways, and Nutrients That Contribute to Colonization. The
streptomycin-treated mouse is a useful model for determining
the relative fitness of enteric bacteria for intestinal colonization
(27–30). The way to find out what an individual strain grows on
in the intestine is to simultaneously feed low numbers (105 cfu
per streptomycin-treated mouse) of the wild-type parent and an
otherwise isogenic mutant that is blocked in a specific metabolic
pathway. Mutant strains that do not compete effectively for
nutrients involved in initiation (5 h to 3 days after feeding) will
fail to reach the same high numbers as the wild type. Mutants
that do not compete effectively for nutrients involved in main-
tenance (day 7 after feeding and beyond) will decline in numbers
relative to the wild type. Cocolonization during the maintenance
stage indicates the strains are able to use limiting nutrients
equally well or they are not competing for the same limiting
nutrient(s).
The mutant with a defect in the Entner–Doudoroff pathway
(edd), the primary route for gluconate catabolism, had a major
colonization defect characterized by failure to grow rapidly
during initiation and a subsequent reduction to less than 103
cfug of feces during maintenance (Fig. 2A). The mutant with a
defect in transport of NAG and glucosamine (nagE manXYZ)
had a significant defect in initiation, but no apparent defect in
maintenance, as indicated by its cocolonization with the wild-
type parent at a 2 log lower population (Fig. 2B). The mutant
with a defect in transport and catabolism of sialic acid (nanAT)
had a significant defect in initiation and possibly maintenance
(Fig. 2C).
Mutants with defects in catabolism of fucose (fucK, Fig. 2D
and fucAO, not shown) initiated colonization as well as the
wild-type parent, but each had a significant defect during
maintenance characterized by a population level 11⁄2 to 2 logs
lower than the wild-type parent. The mutant with a defect in
catabolism of mannose (manA, not shown) had a significant
defect (2–3 logs lower) in maintenance. The mutant with
a defect in catabolism of ribose (rbsK, not shown) had a minor
defect (1–2 logs lower) in maintenance. The mutant with
a defect in catabolism of hexuronic acids (uxaC, not shown) had
Table 1. Genes significantly* induced by mucus
Functional group Phase 1 Phase 2
Amino acid biosynthesis gcvH ilvG
Carbon compound catabolism ansB gntK hycI nanA rbsK tnaA uxaA uxaB
uxaC uxuA
ansB eutJ eutM eutN eutP eutQ eutT
fucA fucO gabT tnaA
Cell processes cspE flaG flgB flgC flgD flgE flgF flgG flgK
flgL fliC fliL htpG motB mukB
cspD cspE flgB flgC flgD flgE flgG flgK
flgL fliC glgS katG motB
Central intermediary metabolism aphA aspA fruK glpK glpQ pck agp appA aspA glpK glpQ pck sdhB sdhD
DNA replication, repair dksA helD
Energy metabolism atpC frdA frdB frdC glpA glpB glpC pta fdoG fdoH fdoI frdA frdB frdC glpA glpB
glpC hyfD
Hypothetical, unclassified, unknown b1937 fliZ yaiN ygaZ yhbU yjeE yjiY yjjI
ymfJ
b1937 ybhO ychH ydaA yfcZ yhbS yhbT
yqeC
Nucleotide biosynthesis, metabolism deoB deoC
Phage, transposon, or plasmid pspE
Putative cell structure ynaF
Putative enzymes hybC mipB ybiW ycgT ygjH gatZ paaH pepB prpC ydfI yeiT ygbD
ygeX ygeY yqeF
Putative factors yraI yliH
Putative membrane protein ompW ompW
Putative regulatory proteins ybjN yfiA
Putative transport proteins yidE ftnB ygbN
Regulatory function asnC cspA glnD tar tsr gatR 3 glnD phoH tar
Transcription, RNA processing rhoL
Translation, rplC rplD rplF rplP rplV rplW rpmC rpmD rplD rplK
posttranslational modification rpsC rpsN rpsQ rpsS rpsT rpsU
Transport and binding proteins exuT lamB malE manX manZ rbsB rbsD
secG uhpT
dcuA gatA gatC glpT
*Significantly induced genes: log ratio 2 standard deviations from mean of log ratios and P  0.0002.
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a minor defect in maintenance (1–2 logs lower). It appears that
the colonization defect is in glucuronate catabolism, because the
defect in galacturonate catabolism (uxaB, not shown) resulted
in no loss of colonizing ability. Genes and corresponding nutri-
ents that did not appear to be used by E. coli MG1655 in the
mouse intestine, despite being induced when grown on mucus,
included ethanolamine (eutBC), glycerol 3-phosphate released
from phospholipids (glpTQ), glycerol (glpK), fructuronate
(gntP), glucuronate released from oligosaccharides by -glu-
curonidase (uidA), tryptophan (tnaA), and gluconeogenic
nutrients (ppsA pckA, shown as an example in Fig. 2E).
Order of in Vitro Nutrient Preference. We tested the hypothesis that
the relative importance of these nutrients for colonization is
correlated with the genetic program for nutrient preference. The
order of nutrient choice was determined by measuring growth on
combinations of carbon sources in laboratory cultures. Using
standard microbiology methods, we looked for the presence of
diauxie, and where it was not present we used biochemical assays
to confirm the timing of the disappearance of individual sugars
from the mixture. The relative impact of the metabolic lesions on
colonization fitness does, in fact, parallel the order of nutrient
preference in vitro for E. coli MG1655: gluconate  NAG 
sialic acid  glucuronic acid  mannose  fucose  ribose
(Table 2).
Colonization of Central Metabolism Mutants. Given the essential
role of intermediary metabolism, it can be hypothesized that any
mutant in central pathways will be defective in colonization
because of a diminished growth rate, even on carbon sources that
are catabolized via different routes. If this is true, the major
effect of the edd mutation on colonization could be ascribed to
its centrality rather than its specificity for hexonate catabolism.
To test this hypothesis, we constructed mutants that are
defective in glycolysis (pgi, phosphoglucose isomerase), the
pentose phosphate pathway (gnd, 6-phosphogluconate dehydro-
genase), the TCA cycle (sdhB, succinate dehydrogenase), and
gluconeogenesis (ppsA pckA, phosphoenolpyruvate synthase and
phosphoenolpyruvate carboxykinase, respectively). A gnd muta-
tion causes an 11% decrease in the growth rate on gluconate and
a 15% decrease in the growth rate on glucose by comparison to
the wild type; a pgi mutant grows 35% slower on gluconate than
does the wild type (31). An edd mutant grows on glucose with
a rate identical to that of the wild type, but grows 60–70% more
slowly on gluconate (32).
Colonization of the MG1655 edd and ppsA pckA mutants was
described above (Fig. 2 A and E). The former had a major effect
and the latter had no effect on colonization. The pgi mutation
had a major effect on initiation and maintenance (Table 3). The
sdhB and gnd mutations had no effect on colonization (Table 3).
Thus, the hypothesis that lesions in central metabolism de-
creased fitness of E. coli MG1655 for colonization was not
supported. The colonization defects of the pgi and edd mutants
were likely caused by defects in catabolism of specific nutrients,
and not simply because they are steps in central carbon metab-
olism. Because the TCA cycle and gluconeogenesis mutants were
Fig. 2. Colonization of the mouse intestine by E. coli MG1655 StrR NalR
(wild-type) and mutant derivatives of E. coli MG1655 StrR, as follows. Sets of
three mice were fed one of the following: 105 cfu each of wild-type and
MG1655 StrR edd::KmR (KmR, kanamycin-resistant) (A); 105 cfu each of wild-
type and MG1655 StrRmanXYZ::KmRnagE (B); 105 cfu each of wild-type and
MG1655 StrR nanAT::KmR (C); 105 cfu each of wild-type and MG1655 StrR
fucK::KmR (D); or 105 cfu each of wild-type and MG1655 StrR ppsA
pckA::Cm (E). At the indicated times, fecal samples were homogenized,
diluted, and plated as described (13). Bars represent standard error of the
log10(mean cfug of feces) for each set of three mice.
Table 2. Growth and nutrient preference of E. coli MG1655
Sugar In vitro growth rate,  Order in vitro Stage in vivo
Gluconate 0.59  0.04 1 I, M
NAG 0.35  0.01 2 I
Sialic acid ND 3 I
Glucuronate 0.35  0.04 3 M
Mannose 0.35  0.03 5 M
Fucose 0.31  0.05 6 M
Ribose 0.19  0.03 7 M
Standing cultures: Mops minimal medium with 0.2% sugar.  is expressed
in generations per hour; ND, not determined; I, initiation; M, maintenance.
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fit for colonization, this ruled out a major role for catabolism of
lipids, dicarboxylates, and amino acids in colonization by E. coli
MG1655.
Discussion
In this study, we conducted a genome-wide search for meta-
bolic pathways that allow E. coli K-12 (MG1655) to colonize
the mouse intestine. In the absence of a suitable in vivo model,
we designed in vitro conditions to mimic nutrient availability in
the mammalian intestine. The bacteria were cultured on
minimal medium with mucus, which contains 50% mucin in
addition to a complex mixture of glycoproteins and glycolipids,
as well as cell debris (15). Cultivation without shaking results
in partially anaerobic conditions, which most closely ref lects
the limited oxygen availability of mucosal tissues in the mouse
intestine (33). A disadvantage of this in vitro model is that it
does not mimic the growth parameters or microbial competi-
tion that exists in the animal intestine. This model did allow us
to use whole-genome expression profiling to reveal genes
induced by growth on mucus. Most were nutritional genes
corresponding to catabolic pathways for nutrients found in
mucus (Table 1). We systematically knocked out these path-
ways and tested the mutants for their relative fitness for
colonization in competition with their wild-type parent. More
than half of the metabolic lesions tested had no effect on the
ability of E. coli MG1655 to colonize the mouse intestine (e.g.,
Fig. 2E). We found that only mutations in sugar pathways
affected colonization, not mutations in phospholipid and
amino acid catabolism, gluconeogenesis, the TCA cycle, and
the pentose phosphate pathway (Tables 2 and 3).
Rapid growth of E. coli during the initiation stage likely
depends on utilization of nonlimiting nutrients made available by
removing the streptomycin-sensitive facultative microflora, i.e.,
nutrients that the anaerobic flora apparently does not use. In
fact, E. coli could not grow from 105 to 108 cfu per gram of feces
if nutrients were limiting (Fig. 2 A). While it might be argued that
rapid growth during initiation is an artifact of streptomycin
treatment, it is for this reason that the streptomycin-treated
mouse is so useful: nutrient consumption during initiation
reflects the in vivo nutrient preference. Conventionally colo-
nized mice (i.e., not streptomycin-treated) are resistant to col-
onization because the preferred nutrients are not available (34).
Thus, the maintenance stage is more akin to persistent coloni-
zation of the intestine (it is at this stage that mice become
colonization resistant). During maintenance, the growth rate of
colonized strains must match the turnover rate of the mucosal
contents (6), and persistence most likely depends on nutrient(s)
that become limiting after E. coli has grown to high numbers.
One microbial strategy for persistence during maintenance
might be to switch to cometabolism of several limiting nutrients.
In the laboratory, E. coli K-12 can grow on 11 of the 13 known
sugar constituents of mucosal glycoproteins and glycolipids (15).
In vivo, only a subset of these sugars appeared to be involved in
colonization. Gluconate was the major carbon source used by E.
coli MG1655 to colonize, having an impact on both the initiation
and the maintenance stages (Fig. 2 A). The effect of the edd
mutation on colonization could be attributed to its specificity for
gluconate catabolism, because the hypothesis was not supported
that lesions in central metabolism decreased fitness for coloni-
zation. NAG and sialic acid were involved in initiation, but not
maintenance (Fig. 2 B and C). Glucuronate, mannose, fucose
(Fig. 2D), and ribose were involved in maintenance, but not
initiation. The order of preference for these seven sugars in the
laboratory paralleled the relative impact of the corresponding
metabolic lesions on E. coli MG1655 colonization (Table 2). The
results are intriguing, in light of the nutrient-niche hypothesis:
colonization of the mouse intestine by E. coli MG1655 is
supported, to various degrees, by (at least) seven mucus-derived
sugars.
Two sugars that E. coli K-12 cannot grow on because it lacks
the pathway genes, galactosamine and N-acetylgalactosamine,
can be used by other E. coli strains (35). Differences in metabolic
potential due to the presence or absence of certain pathways
could provide a nutritional basis for cocolonization. This pos-
sibility has not been tested, but if true, it could be extended to
include differences in the order of consumption of preferred
nutrients from complex mixtures such as mucus.
The nutrient-niche hypothesis (6) can be reconsidered in
light of what we have learned about the nutrients used by E.
coli to colonize the mouse intestine. The hypothesis is over-
simplified if considered from the perspective that each of the
500 species present grows best on a single simple nutrient;
there simply are not that many nutrients available in the
ecosystem. Instead, it seems prudent to consider that the
complex microbial community of the intestine is established by
competition for diverse nutrients that are generated in the
intestine through mucosal polysaccharide degradation to re-
lease free sugars and distinct oligosaccharides with various
carbohydrate compositions (10).
For bacteria in the mammalian intestine, as in a chemostat,
the growth rate in the initiation stage must exceed the washout
rate and the growth rate during the maintenance stage must
equal the washout rate (6, 36). Two different microorganisms
with a preference for the same growth-limiting nutrient cannot
coexist in chemostats; one will eventually out-compete the
other (37). However, if two microorganisms use different
growth-limiting nutrients, they can maintain stable popula-
tions in a chemostat (38). Thus the mammalian intestine can
be thought of as a chemostat in which several hundred species
of bacteria are in equilibrium, competing for resources from a
mixture of limiting nutrients (6, 39). The chemostat allows for
simultaneous utilization of several limiting nutrients by an
individual species (40). It remains to be established whether
this observation extends to in vivo nutrient utilization by E.
coli. The fact that seven, or more, nutrients support E. coli
colonization suggests that cometabolism of available nutrients
in the intestine is worthy of study.
The systematic analysis of E. coli MG1655 described here
suggests that there is a nutritional basis for the steady progres-
sion of commensal strains in human hosts (34). Further studies
are needed to address the hypothesis that preferential utilization
of different nutrients andor the ability to switch to alternative
nutrition is the basis for cocolonization of different E. coli strains
and that direct competition for the same nutrient(s) leads to
decreased fitness of some strains. The results of such studies may
explain how various commensal strains affect nutrient availabil-
ity, in some cases providing an open niche for infecting E. coli
pathogens and in other cases preventing infection. For example,
it is known that certain E. coli strains can prevent Shigella flexneri
(41) and Salmonella typhimurium (42) infection in mice. Hence,
Table 3. Colonization by E. coli MG1655 central
metabolism mutants
Mutation Pathway
Colonization
defect*
Phase of
colonization†
edd Entner–Doudoroff Major I, M
pgi Glycolysis Major I, M
sdhB TCA cycle None
gnd Pentose phosphate None
ppsA pckA Gluconeogenesis None
*Major, 3 logs between wild type and mutant; none, 1 log between wild
type and mutant.
†I, initiation (5 h to day 3); M, maintenance (after day 7).
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individual differences in the E. coli f lora could be the reason for
differences in human susceptibility to gastroenteritis (43). If so,
there is the opportunity to build a nutritional framework for
understanding how commensal strains serve as the first line of
defense against intestinal infections.
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